Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives

BACKGROUND: A 12-dose, once-weekly regimen of isoniazid and rifapentine (3HP) is effective in preventing tuberculosis (TB) among people living with HIV (PLHIV). We sought to identify potential barriers to and facilitators of acceptance and completion of 3HP treatment from the perspective of people l...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Implement Sci Commun
Egile Nagusiak: Semitala, Fred C., Musinguzi, Allan, Ssemata, Jackie, Welishe, Fred, Nabunje, Juliet, Kadota, Jillian L., Berger, Christopher A., Katamba, Achilles, Kiwanuka, Noah, Kamya, Moses R., Dowdy, David, Cattamanchi, Adithya, Katahoire, Anne R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2021
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247167/
https://ncbi.nlm.nih.gov/pubmed/34193311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s43058-021-00173-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak